Skip to content

Establishment of a risk stratification scoring system for predicting hypertensive patients based on multimodal data

Establishment of a risk stratification scoring system for predicting hypertensive patients based on multimodal data

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074392
Enrollment
Unknown
Registered
2023-08-04
Start date
2023-08-06
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

hypertensive group:NA

Sponsors

The People's Hospital of Xuancheng City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. age between 18 and 95 years; 2. a diagnosis of hypertension at the time of admission;

Exclusion criteria

Exclusion criteria: 1. secondary hypertension; 2. prior coronary artery bypass graft surgery. 3. comorbid severe heart valve disease; 4. active myocarditis 5. active pericarditis 6. severe infections; 7. severe renal insufficiency (eg. 7. severe renal insufficiency (eGFR < 30 ml/min) 8. rheumatologic diseases; 9. mental or legal incapacity. 10. drug or alcohol abuse within the last 2 years. 11. patients with an underlying rhythm other than sinus rhythm (e.g., atrial flutter, atrial fibrillation, severe atrioventricular block, and pacemaker implantation; 12. the presence of tumor-related diseases 13. the presence of other diseases that have an impact on autonomic function, such as hyperthyroidism, psychiatric or neurological disorders.

Design outcomes

Primary

MeasureTime frame
Main Adverse Cardiovascular and Cerebrovascular Events ( Main Adverse Cardiovascular and Cerebrovascular Events, MACCEs ) detected on follow-up;Routine baseline data of hypertensive patients and data from hospital admission tests;

Countries

China

Contacts

Public ContactLong Tang

15 Huancheng Road North, Xuanzhou District, Xuancheng, Anhui, China

812595591@qq.com+86 189 5630 0320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026